With just 3 affected individuals, researchers find gene behind rare form of epilepsy

Researchers have found a gene responsible for a particularly debilitating form of epilepsy that also leads to kidney failure, according to a report published online on February 28th and also in the March 7th print issue of the American Journal of Human Genetics, a publication of Cell Press. What’s more, the new findings, which begin to “crack open the cell biology of the problem,” were made with the help of just three affected individuals.

“Many people will not have heard of this extraordinarily rare disease,” said Samuel Berkovic of the University of Melbourne in Australia. “Nonetheless, the findings speak to the power of genetics to solve even quite rare problems.”

Epilepsy is overall a common condition, affecting some two percent of people. The genetics behind the seizure disorder are often complex. However, progressive myoclonus epilepsies, which Berkovic said can be quite disabling and tend to get worse over time, usually have a simpler, Mendelian pattern of inheritance caused by a variety of single genes.

Action myoclonus-renal failure (AMRF) syndrome is a lethal inherited form of progressive myoclonus epilepsy associated with kidney failure. Symptoms usually arise when people reach the age of 15–25 with signs of kidney trouble or neurological symptoms including tremors, seizures, and later other movement disorders. Upon close inspection, the kidneys of those with AMRF show scarring, and their brains show an unusual buildup of storage material.

“The recessive gene defect underlying AMRF was unknown and the lack of large pedigrees and lethality of the disorder precluded a conventional mapping strategy,” Berkovic said. So, his team came up with a new one.

The researchers first identified three unrelated families, each with a member having AMRF. They then used a modified version of “homozygosity mapping” to narrow the candidate regions of the genome down to places where both copies of a gene were identical in one inbred family, and they used affected and unaffected family members to narrow the hunt further. That exercise suggested that the gene involved could be found in a region on chromosome 4.

Then, they took another “quick shortcut” to finding the culprit, Berkovic said. Using microarray analysis, which measures gene expression, they identified genes within the implicated region that were turned down in those with AMRF.

That led them to SCARB2/Limp2as the likely candidate. Indeed, they showed, all of the families under study carried a mutation in the SCARB2/Limp2gene, which the researchers confirmed in two other unrelated AMRF families.

SCARB2/Limp2is active in a wide range of tissues, earlier studies had shown, where it is found on the surface of cellular components called lysosomes. Lysosomes play an important role inside of cells in breaking down spent parts, a process known as autophagy.

As luck would have it, mice lacking the gene had already been developed. Upon examination of those animals, the investigators found inclusions in the animals’ brains and subtle abnormalities in their kidneys, reminiscent of people with AMRF.

Although further study is needed to work out exactly what happens in the brain and kidneys of people lacking this lysosomal gene, Berkovic said they do have some ideas.

“SCARB2/Limp2 might have a role in physiological autophagy and its deficiency could thus lead to accumulation of normally recycled proteins or organelles manifesting as inclusions [in the brain],” the researchers said.

On top of the insights into AMRF, the team’s newly developed method might unlock other rare disorders.

“The whole trick is to exploit the particular family structure of affected and unaffected individuals,” Berkovic said. “This strategy may be more widely applicable to the still many rare, Mendelian disorders yet to be solved.”

Source: Cell Press

Related stories:

Childhood epilepsy research offers new hope for seizure control
Scientists still do not know what causes epileptic seizures, but researchers from Melbourne’s Howard Florey Institute are one step closer to solving this puzzle with the help of their newly developed genetically modified epileptic mouse.
Potential treatment for TB solves puzzle
Scientists have uncovered a new target for the potential treatment of TB, finally resolving a long-running debate about how the bacterial cell wall is built. The research, published in the July issue of Microbiology reveals several molecules that could be developed into drugs to treat tuberculosis.
Parasite vaccines within reach
Even though parasites are complex creatures, the mammalian immune response to them is surprisingly simple, leading University of California, Berkeley, researchers to predict that creating vaccines for parasitic diseases such as malaria may be more straightforward than initially thought.
Resveratrol found to improve health, but not longevity in aging mice on standard diet
Scientists have found that the compound resveratrol slows age-related deterioration and functional decline of mice on a standard diet, but does not increase longevity when started at middle age. This study, conducted and supported in part by the National Institute on Aging (NIA), part of the National Institutes of Health, is a follow-up to 2006 findings that resveratrol improves health and longevity of overweight, aged mice. The report confirms previous results suggesting the compound, found naturally in foods like grapes and nuts, may mimic, in mice, some of the effects of dietary or calorie restriction, the most effective and reproducible way found to date to alleviate age-associated disease in mammals.
Red wine ingredient wards off effects of age on heart, bones, eyes and muscle
Large doses of a red wine ingredient can ward off many of the vagaries of aging in mice who begin taking it at midlife, according to a new report published online on July 3rd in Cell Metabolism, a Cell Press publication. Those health improvements of the chemical known as resveratrol—including cardiovascular benefits, greater motor coordination, reduced cataracts and better bone density—come without necessarily extending the animals' lifespan.
'Smart' materials get smarter with ability to better control shape and size
A dynamic way to alter the shape and size of microscopic three-dimensional structures built out of proteins has been developed by biological chemist Jason Shear and his former graduate student Bryan Kaehr at The University of Texas at Austin.
New antibiotic beats superbugs at their own game
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them. Rockefeller University scientists tested the new drug, called Ceftobiprole, against some of the deadliest strains of multidrug-resistant Staphylococcus aureus (MRSA) bacteria, which are responsible for the great majority of staphylococcal infections worldwide, both in hospitals and in the community.
Texas A&M researchers develop tool to study complex clusters of genes
Texas A&M University researchers have developed a computational tool that will help scientists more accurately study complex units of clustered genes, called operons, in bacteria.

News discussion:

Medicine & Health news